Back
HFA Premium Access

Reaching the next level of drug development for heart failure: targetting mitochondria.

Session: Targeting mitochondria to improve outcomes in heart failure
Topic: Cell Signalling
Speaker: Professor S. Anker (Berlin, DE)
Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Stealth Peptides
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)
171 presentations
11 followers

3 more presentations in this session

Elamipretide improves mitochondrial activity in the failing human heart.

Speaker: Doctor B. Stauffer (Aurora, US)

Access
Like
Thumbnail

Elamipretide in heart failure with reduced ejection fraction.

Speaker: Professor H. Sabbah (Detroit, US)

Access
Like
Thumbnail

Clinical development concepts targeting mitochondria.

Speaker: Professor B. Pitt (Ann Arbor, US)

Access
Like
Thumbnail

Access the full session

Targeting mitochondria to improve outcomes in heart failure

Speakers: Professor S. Anker, Doctor B. Stauffer, Professor H. Sabbah, Professor B. Pitt
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources